TP53 and ovarian serous adenocarcinoma: Interestingly, in advanced serous ovarian cancer tissue with mutant TP53 gene, Δ133p53α expression was associated with improved disease-free survival and overall survival, providing preliminary evidence that the mutational status of TP53 can influence the association between p53 isoform expression and patients’ clinical outcome.